share_log

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jerman Michael Allen

SEC ·  Feb 8, 2024 17:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more